7.52
前日終値:
$7.80
開ける:
$7.69
24時間の取引高:
7,012
Relative Volume:
0.21
時価総額:
$8.04M
収益:
$630.00K
当期純損益:
$5.72M
株価収益率:
-22.02
EPS:
-0.3415
ネットキャッシュフロー:
$-6.75M
1週間 パフォーマンス:
+2.24%
1か月 パフォーマンス:
-2.21%
6か月 パフォーマンス:
-1.05%
1年 パフォーマンス:
-27.78%
Addex Therapeutics Ltd Adr Stock (ADXN) Company Profile
ADXN を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ADXN
Addex Therapeutics Ltd Adr
|
7.52 | 8.04M | 630.00K | 5.72M | -6.75M | -0.3415 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Addex Therapeutics Ltd Adr Stock (ADXN) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-07-31 | アップグレード | H.C. Wainwright | Neutral → Buy |
Addex Therapeutics Ltd Adr (ADXN) 最新ニュース
Coincheck Group N.V (CNCK) produces promising results - US Post News
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo Finance
Addex Stock Soars on Crucial Update From Indivior Research Deal - MSN
Golden Heaven Group secures investment of $25.2M - MSN
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? - Yahoo Finance
Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024 - GlobeNewswire Inc.
Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Positive Trial Data on Symplicity RDN System Likely to Support MDT Stock - MSN
Are Medical Stocks Lagging Boston Scientific (BSX) This Year? - Yahoo Finance
Drug discovery and bringing new medicine to marketthe future of AI in pharma - OutSourcing-Pharma.com
What Makes Addex Therapeutics (ADXN) a New Buy Stock - Yahoo Finance
Earnings call: Addex Therapeutics reports half-year financials and R&D updates By Investing.com - Investing.com South Africa
Earnings call: Addex Therapeutics reports half-year financials and R&D updates - Investing.com
ADMA Biologics stock soars to all-time high of $19.36 - Investing.com
ADMA Biologics Stock Soars 76.2% in 3 Months: Right Time to Invest? - Zacks Investment Research
ADMA Biologics (NASDAQ:ADMA) Reaches New 52-Week High at $19.42 - MarketBeat
ADXN Stock on the Rise: A Promising Investment - The InvestChronicle
There Are Mixed Signals on the Chart for Addex Therapeutics Ltd ADR (ADXN) - US Post News
Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder - Yahoo Finance
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Why Philips Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket - Benzinga
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
ADXN Stock Price and Chart — SIX:ADXN - TradingView
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Addex Therapeutics Ltd Adr (ADXN) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):